To include your compound in the COVID-19 Resource Center, submit it here.

FF-10501: Phase I/IIa started

Fujifilm's Fujifilm Corp. subsidiary began an open-label, dose-escalation, U.S. Phase I/IIa trial of oral FF-10501 given twice

Read the full 170 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE